Depression and Anxiety Disorders in Patients With Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Mental health is a significant yet overlooked aspect of inflammatory bowel disease (IBD) patient care, with challenges in determining optimal treatments and psychological health resources. The most common psychological conditions in patients with IBD are anxiety and depression. The increased prevalence of these mental disorders appeals to mental screening of each person diagnosed with IBD at initial consultation. There are simple and clinically viable methods available to screen for mental problems. Psychological methods may be as or even more significant as a therapeutic modality. Herein we discuss the three major areas of psychological co-morbidity in IBD: (1) the prevalence and risk factors associated with anxiety and depression disorders for patients with IBD; (2) diagnosis of psychological disorders for patients with IBD; (3) treatment with patients with IBD and mental disorders. The gastroenterologists are encouraged to screen and treat these patients with IBD and mental disorders, which may improve outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.011 · Cited by 5,128
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741 · cited 1×
“It has demonstrated good reliability and structural validity (47, 48).”
BackgroundThe WHO-5 well-being index: A systematic review of the literature
Topp, C. W., Østergaard, S. D., Søndergaard, S., & Bech, P. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000376585 · Cited by 4,708
Löwe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., & Herzberg, P. Y. (2008) · Medical Care · doi:10.1097/mlr.0b013e318160d093 · Cited by 4,527 · cited 1×
“It has demonstrated good reliability and structural validity (47, 48).”
BackgroundThe molecular neurobiology of depression
Krishnan, V., & Nestler, E. J. (2008) · Nature · doi:10.1038/nature07455 · Cited by 2,889 · cited 1×
“In conclusion, new onset of disease, disease activity, side effects of medications, stressful life events, inpatient status and lower socioeconomic status can easily affect the mood of one or two types of IBD (22).”
BackgroundMeditation Programs for Psychological Stress and Well-being: A Systematic Review and Meta-analysis
Goyal, M., Singh, S., Sibinga, E. M. S., Gould, N. F., Rowland-Seymour, A., Sharma, R., Berger, Z., Sleicher, D., Maron, D. D., Shihab, H. M., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13018 · Cited by 2,380
Pilkonis, P. A., Choi, S. W., Reise, S. P., Stover, A. M., Riley, W. T., Cella, D., & PROMIS Cooperative Group (2011) · Assessment · doi:10.1177/1073191111411667 · Cited by 2,132
Manea, L., Gilbody, S., & McMillan, D. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.110829 · Cited by 1,966
Severity classification on the Hamilton depression rating scale
Zimmerman, M., Martinez, J. H., Young, D., Chelminski, I., & Dalrymple, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.028 · Cited by 1,199 · cited 1×
“Hamilton Rating Scale (HAM) Hamilton Anxiety Rating Scale (HAM-A) and Hamilton Depression Rating Scale (HAM-D) are the two oldest tools for assessing anxiety and depression (36, 37).”
MethodBarberio, B., Zamani, M., Black, C. J., Savarino, E. V., & Ford, A. C. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00014-5 · Cited by 758 · cited 4×
“The questionnaire scales and cutoff used to define presence of patients with symptoms of anxiety or depression were different (10).”
BackgroundInfluentialDepression and anxiety in patients with Inflammatory Bowel Disease: a systematic review
Neuendorf, R., Harding, A., Stello, N., Hanes, D., & Wahbeh, H. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.06.001 · Cited by 561 · cited 1×
“One systematic review showed that patients with IBD had ∼15 and 20%prevalence rate of depression and anxiety respectively (13).”
BackgroundMittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Miehsler, W., Beier, M., Tillinger, W., Gangl, A., & Moser, G. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000106907.24881.f2 · Cited by 532
Derogatis, L. R., & Unger, R. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0970 · Cited by 488 · cited 1×
“Symptom Checklist Anxiety Scale (SCL-A20) SCL-A20 is a subscale of Symptom Checklist 90 Revised (SCL90R) designed by Derogatis LR, which composed of 20 items and is used as a screening tool for anxiety (45).”
MethodWalker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., Rawsthorne, P., Miller, N., Rogala, L., McPhail, C. M., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01980.x · Cited by 437 · cited 2×
“In another population-based cohort study in Canada, nearly 80% of patients with IBD and anxiety were diagnosed with anxiety more than 2 years before the diagnosis of IBD (11).”
BackgroundBi-directionality of brain–gut interactions in patients with inflammatory bowel disease
Gracie, D. J., Guthrie, E. A., Hamlin, P. J., & Ford, A. C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.027 · Cited by 408 · cited 2×
“Therefore, the occurrence of anxiety and depression may be related to the manifestations of active intestinal inflammation related to brain-gut axis imbalance (6, 7).”
BackgroundAli, G.-C., Ryan, G., & De Silva, M. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0156939 · Cited by 358 · cited 1×
“include self-reported or clinician-reported approaches, and structured clinician psychiatric interviews (25).”
BackgroundMikocka-Walus, A., Pittet, V., Rossel, J.-B., von Känel, R., Anderegg, C., Bauerfeind, P., Beglinger, C., Begré, S., Belli, D., Bengoa, J. M., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.045 · Cited by 348 · cited 1×
“In a cohort of 2,007 patients followed over 9 years from the Swiss, the results showed an association between depressive symptoms and clinical recurrence of IBD (20).”
BackgroundThe GAD-7 scale was accurate for diagnosing generalised anxiety disorder
Swinson, R. P. (2006) · Evidence-Based Medicine · doi:10.1136/ebm.11.6.184 · Cited by 323
Frolkis, A. D., Vallerand, I. A., Shaheen, A.-A., Lowerison, M. W., Swain, M. G., Barnabe, C., Patten, S. B., & Kaplan, G. G. (2019) · Gut · doi:10.1136/gutjnl-2018-317182 · Cited by 228 · cited 1×
“In addition, this study showed that SSRIs and TCAs have a protective effect on CD, while mirtazapine, SNRIs, SSRIs, serotonin modulators and TCAs have a protective effect on UC (85).”
ResultKroenke, K., Yu, Z., Wu, J., Kean, J., & Monahan, P. O. (2014) · Pain Medicine · doi:10.1111/pme.12537 · Cited by 187 · cited 2×
“Among other outcome variables, the PROMIS instrument generates anxiety and depression scores (33).”
BackgroundMethodMental disorders in primary care
Wittchen, H.-U., Mühlig, S., & Beesdo, K. (2003) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2003.5.2/huwittchen · Cited by 180
Depression is associated with more aggressive inflammatory bowel disease
Kochar, B., Barnes, E. L., Long, M. D., Cushing, K. C., Galanko, J., Martin, C. F., Raffals, L. E., & Sandler, R. S. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.423 · Cited by 178
Etiology and Treatment of Pain and Psychosocial Issues in Patients With Inflammatory Bowel Diseases
Regueiro, M., Greer, J. B., & Szigethy, E. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.036 · Cited by 142
Szigethy, E. M., Allen, J. I., Reiss, M., Cohen, W., Perera, L. P., Brillstein, L., Cross, R. K., Schwartz, D. A., Kosinski, L. R., Colton, J. B., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.02.037 · Cited by 107
Cámara, R. J. A., Ziegler, R., Begré, S., Schoepfer, A. M., & von Känel, R. (2009) · Digestion · doi:10.1159/000226087 · Cited by 106
Psychotherapy for inflammatory bowel disease: a review and update
McCombie, A. M., Mulder, R. T., & Gearry, R. B. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.02.004 · Cited by 105
Generalized anxiety disorder and the Hamilton anxiety rating scale in Parkinson's disease
Kummer, A., Cardoso, F., & Teixeira, A. L. (2010) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2010000400005 · Cited by 103 · cited 1×
“Through continuous use of the scale, doctors can evaluate the results of medication or psychotherapy (38).”
BackgroundGerbarg, P. L., Jacob, V. E., Stevens, L., Bosworth, B. P., Chabouni, F., DeFilippis, E. M., Warren, R., Trivellas, M., Patel, P. V., Webb, C. D., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000568 · Cited by 103
The effect of hypnosis on systemic and rectal mucosal measures of inflammation in ulcerative colitis
Mawdsley, J. E., Jenkins, D. G., Macey, M. G., Langmead, L., & Rampton, D. S. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01845.x · Cited by 102
Tricyclic Antidepressants for Management of Residual Symptoms in Inflammatory Bowel Disease
Iskandar, H. N., Cassell, B., Kanuri, N., Gyawali, C. P., Gutierrez, A., Dassopoulos, T., Ciorba, M. A., & Sayuk, G. S. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000049 · Cited by 96 · cited 1×
“A second retrospective study found that high-dose TCA prescribed for depression can reduce disease episodes, endoscopy and steroid use (76).”
BackgroundAntidepressants in inflammatory bowel disease
Mikocka-Walus, A., Ford, A. C., & Drossman, D. A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0259-y · Cited by 93 · cited 1×
“Along with psychotherapy, antidepressants have been recognized as treatments for gut–brain disorders that might benefit both psychological and gastrointestinal health (67).”
BackgroundAntidepressants in Inflammatory Bowel Disease: A Systematic Review
Macer, B. J. D., Prady, S. L., & Mikocka-Walus, A. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001059 · Cited by 92
Mikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. M. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0278-2 · Cited by 86 · cited 1×
“In CBT, CBT has not been studied to continuously change the outcome of the disease, but it can effectively improve medical compliance and underlying symptoms of anxiety or depression (61, 62).”
BackgroundSzigethy, E., Bujoreanu, S. I., Youk, A. O., Weisz, J., Benhayon, D., Fairclough, D., Ducharme, P., Gonzalez-Heydrich, J., Keljo, D., Srinath, A., et al. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.04.014 · Cited by 86
Neilson, K., Ftanou, M., Monshat, K., Salzberg, M., Bell, S., Kamm, M. A., Connell, W., Knowles, S. R., Sevar, K., Mancuso, S. G., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000629 · Cited by 80
A Comparison of Buspirone and Placebo in Relieving Benzodiazepine Withdrawal Symptoms
LADER, M., & OLAJIDE, D. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198702000-00003 · Cited by 79
Mikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9580-9 · Cited by 78 · cited 1×
“In CBT, CBT has not been studied to continuously change the outcome of the disease, but it can effectively improve medical compliance and underlying symptoms of anxiety or depression (61, 62).”
BackgroundYanartas, Ö., Kani, H. T., Bicakci, E., Kilic, I., Banzragch, M., Acikel, C., Atug, O., Kuscu, K., Imeryuz, N., & Akin, H. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s106039 · Cited by 69 · cited 2×
“Prevalence and Risk factors Associated With Anxiety and Depression Disorders Compared with the general population, patients with IBD had a higher lifetime rate of psychiatric disorders such as anxiety and depression, which were known to have negative impact on the quality of their lives and the severity of disease (8,…”
BackgroundTarricone, I., Regazzi, M. G., Bonucci, G., Rizzello, F., Carini, G., Muratori, R., Poggioli, G., & Campieri, M. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.07.001 · Cited by 53
Anxiety but not depression predicts poor outcomes in inflammatory bowel disease
Narula, N., Pinto-Sanchez, M. I., Calo, N. C., Ford, A. C., Bercik, P., Reinisch, W., & Moayyedi, P. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy385 · Cited by 52 · cited 1×
“Moreover, the results suggested that elevated anxiety HADS scores at baseline was an independent predictor of adverse IBD-related outcomes (17).”
BackgroundEmpirically supported use of psychiatric medications in adolescents and adults with IBD
Thorkelson, G., Bielefeldt, K., & Szigethy, E. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000734 · Cited by 39
Cited by
Cooney, R., Tang, D., Barrett, K., & Russell, R. K. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad169 · Cited by 39
“28 A patient’s mental health and clinical transition experience play critical roles in achieving personal, professional, and treatment-related success.”
BackgroundHinnant, L., Rios Villacorta, N., Chen, E., Bacchus, D., Dotson, J., Greywoode, R., Keefer, L., Lupe, S., Maggs, L., Meek, G., et al. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae151 · Cited by 31
He, Y., Chen, C.-L., He, J., & Liu, S.-D. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i44.5872 · Cited by 10
PSYCHO-EMOTIONAL STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Romanukha, V., Hryniv, O., Hvozdetska, H., Baryla, N., & Hrushetska, A. (2024) · Eastern Ukrainian Medical Journal · doi:10.21272/eumj.2024;12(2):202-211 · Cited by 1
Metadata
- Authors
- Hu, S., Chen, Y., Chen, Y., & Wang, C.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2021-10-08
- Volume
- 12
- Pages
- 714057-714057
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W3207658345
- Cited by
- 87
- References
- 42
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.